BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

685 related articles for article (PubMed ID: 16759341)

  • 1. Glucocorticoid negative feedback in methadone-maintained former heroin addicts with ongoing cocaine dependence: dose-response to dexamethasone suppression.
    Aouizerate B; Ho A; Schluger JH; Perret G; Borg L; Le Moal M; Piazza PV; Kreek MJ
    Addict Biol; 2006 Mar; 11(1):84-96. PubMed ID: 16759341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered HPA axis responsivity to metyrapone testing in methadone maintained former heroin addicts with ongoing cocaine addiction.
    Schluger JH; Borg L; Ho A; Kreek MJ
    Neuropsychopharmacology; 2001 May; 24(5):568-75. PubMed ID: 11282257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic cannabis use does not affect the normalization of hypothalamic-pituitary-adrenal (HPA) axis induced by methadone in heroin addicts.
    Nava F; Manzato E; Lucchini A
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jun; 31(5):1089-94. PubMed ID: 17466429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Corticotropin-releasing factor testing reveals a dose-dependent difference in methadone maintained vs control subjects.
    Schluger JH; Bart G; Green M; Ho A; Kreek MJ
    Neuropsychopharmacology; 2003 May; 28(5):985-94. PubMed ID: 12700714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The low-dose dexamethasone suppression test in fibromyalgia.
    Wingenfeld K; Wagner D; Schmidt I; Meinlschmidt G; Hellhammer DH; Heim C
    J Psychosom Res; 2007 Jan; 62(1):85-91. PubMed ID: 17188125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucocorticoid receptor mediated negative feedback in chronic fatigue syndrome using the low dose (0.5 mg) dexamethasone suppression test.
    Papadopoulos A; Ebrecht M; Roberts AD; Poon L; Rohleder N; Cleare AJ
    J Affect Disord; 2009 Jan; 112(1-3):289-94. PubMed ID: 18573538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic subcutaneous leptin infusion diminishes the responsiveness of the hypothalamic-pituitary-adrenal (HPA) axis in female rhesus monkeys.
    Wilson ME; Fisher J; Brown J
    Physiol Behav; 2005 Mar; 84(3):449-58. PubMed ID: 15763583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mood and neuroendocrine response to a chemical stressor, metyrapone, in buprenorphine-maintained heroin dependence.
    Kakko J; von Wachenfeldt J; Svanborg KD; Lidström J; Barr CS; Heilig M
    Biol Psychiatry; 2008 Jan; 63(2):172-7. PubMed ID: 17850768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adrenocorticotropic hormone and cortisol plasma levels directly correlate with childhood neglect and depression measures in addicted patients.
    Gerra G; Leonardi C; Cortese E; Zaimovic A; Dell'Agnello G; Manfredini M; Somaini L; Petracca F; Caretti V; Baroni C; Donnini C
    Addict Biol; 2008 Mar; 13(1):95-104. PubMed ID: 18201294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dysfunction of the hypothalamic-pituitary-adrenal axis in opioid dependent subjects: effects of acute and protracted abstinence.
    Zhang GF; Ren YP; Sheng LX; Chi Y; Du WJ; Guo S; Jiang ZN; Xiao L; Luo XN; Tang YL; Smith AK; Liu ZQ; Zhang HX
    Am J Drug Alcohol Abuse; 2008; 34(6):760-8. PubMed ID: 19016181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A combined dexamethasone/corticotropin-releasing hormone test in patients with chronic PTSD--first preliminary results.
    Muhtz C; Wester M; Yassouridis A; Wiedemann K; Kellner M
    J Psychiatr Res; 2008 Jul; 42(8):689-93. PubMed ID: 17884095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between plasma cortisol levels, withdrawal symptoms and craving in abstinent and treated heroin addicts.
    Nava F; Caldiroli E; Premi S; Lucchini A
    J Addict Dis; 2006; 25(2):9-16. PubMed ID: 16785214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sensitivity of the hypothalamic-pituitary-adrenal system of pigeons (Columba livia domestica) to suppression by dexamethasone, cortisol, and prednisolone.
    Westerhof I; Van den Brom WE; Mol JA; Lumeij JT; Rijnberk A
    Avian Dis; 1994; 38(3):435-45. PubMed ID: 7832695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opioid receptor imaging with positron emission tomography and [(18)F]cyclofoxy in long-term, methadone-treated former heroin addicts.
    Kling MA; Carson RE; Borg L; Zametkin A; Matochik JA; Schluger J; Herscovitch P; Rice KC; Ho A; Eckelman WC; Kreek MJ
    J Pharmacol Exp Ther; 2000 Dec; 295(3):1070-6. PubMed ID: 11082442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heroin reduces startle and cortisol response in opioid-maintained heroin-dependent patients.
    Walter M; Wiesbeck GA; Degen B; Albrich J; Oppel M; Schulz A; Schächinger H; Dürsteler-MacFarland KM
    Addict Biol; 2011 Jan; 16(1):145-51. PubMed ID: 20331562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Benefits of retention in methadone maintenance and chronic medical conditions as risk factors for premature death among older heroin addicts.
    Fareed A; Casarella J; Amar R; Vayalapalli S; Drexler K
    J Psychiatr Pract; 2009 May; 15(3):227-34. PubMed ID: 19461397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blunted ACTH response to dexamethasone suppression-CRH stimulation in posttraumatic stress disorder.
    Ströhle A; Scheel M; Modell S; Holsboer F
    J Psychiatr Res; 2008 Oct; 42(14):1185-8. PubMed ID: 18342888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biology of posttraumatic stress disorder.
    Yehuda R
    J Clin Psychiatry; 2001; 62 Suppl 17():41-6. PubMed ID: 11495096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adrenal axis function after high-dose steroid therapy for childhood acute lymphoblastic leukemia.
    Einaudi S; Bertorello N; Masera N; Farinasso L; Barisone E; Rizzari C; Corrias A; Villa A; Riva F; Saracco P; Pastore G
    Pediatr Blood Cancer; 2008 Mar; 50(3):537-41. PubMed ID: 17828747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous and intranasal heroin-dependent treatment-seekers: characteristics and treatment outcome.
    Highfield DA; Schwartz RP; Jaffe JH; O'Grady KE
    Addiction; 2007 Nov; 102(11):1816-23. PubMed ID: 17784892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.